Xanthine derivatives as antagonists at A1 and A2 adenosine receptors
The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
A variety of alkylxanthines has been comparatively examined as antagonists of A1 adenosine receptors in rat fat cells, rat and bovine cerebral cortex and of A2 adenosine receptors in human platelets. With few exceptions all xanthine derivatives with 7-position substituents such as diprophylline, proxyfylline, pentoxifylline and etofylline were less potent antagonists than xanthine itself which had Ki-values of 170 mumol/l (A1) and 93 mumol/l (A2). Theophylline, caffeine and 3-isobutyl-1-methylxanthine were more potent than xanthine but nearly equipotent antagonists at both receptor subtypes. 8-Phenyl substituents considerably increased the antagonist potency at A1 and A2 receptors. 1,3-Diethyl-8-phenylxanthine was the most potent A2 antagonist (Ki 0.2 mumol/l) in human platelets. At A1 receptors 1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine (PACPX) was the most potent antagonist in all three tissues with Ki-values from 0.3 to 8.6 nmol/l. Several 8-phenylxanthine derivatives were remarkably selective antagonists at A1 receptors. 8-Phenyltheophylline was approximately 700 times more potent as antagonist at A1 receptors (bovine brain) than at A2 receptors (human platelets), and PACPX was even 1,600 times more potent as A1 adenosine receptor antagonist. These compounds offer a possibility for a subtype-selective blockade of adenosine receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This mechanism promotes increased release of catecholamines from the adrenal medulla [ 6 ], stimulating glycogenolysis and lipolysis [ 6 , 7 ].”
From Involvement of Cardiorespiratory Capacity on the Acute Effects of Caffeine on Autonomic Recovery (2019) · cites this paper as [6]
In the citing paper
“Two suggested mechanisms for how CAF influences cardiovascular function include the activation of the sympathetic autonomic system through catecholamines released into the bloodstream [ 12 ] and the inhibition of adenosine receptors (A1, A2A, A2B) in the central nervous system [ 13 ].”
From Impact of Caffeine Intake Strategies on Heart Rate Variability during Post-Exercise Recovery: A Systematic Review and Meta-Analysis (2024) · cites this paper as [13]
In the citing paper
“Due to its structural similarity, caffeine can lead to the blockading of adenosine receptors (A1 and A2)4”
From Caffeine affects autonomic control of heart rate and blood pressure recovery after aerobic exercise in young adults: a crossover study (2017) · cites this paper as [4]
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Metabolism of Isolated Fat Cells
Rodbell, M. (1964) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51687-2 · Cited by 4,427
METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS.
Rodbell, M. (1964) · PubMed · Cited by 1,387
Subclasses of external adenosine receptors.
Londos, C., Cooper, D. M., & Wolff, J. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.2551 · Cited by 1,081
Adenosine receptors: targets for future drugs
Daly, J. W. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00345a001 · Cited by 683
The enzymatic preparation of [α-32P]nucleoside triphosphates, cyclic [32P]AMP, and cyclic [32P]GMP
Walseth, T. F., & Johnson, R. A. (1979) · Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis · doi:10.1016/0005-2787(79)90122-9 · Cited by 573
Bruns, R. F., Daly, J. W., & Snyder, S. H. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5547 · Cited by 548
Are Methylxanthine Effects Due to Antagonism of Endogenous Adenosine?
Fredholm, B. B. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90046-4 · Cited by 409 · cited 1×
“For many years these compounds were believed to act via an inhibition of cyclic nucleotide phosphodiesterases, but now it has been recognized that theophylline and other xanthine derivatives have additional effects on adenosine receptors and are more potent as adenosine antagonists than as inhibitors of phosphodiester…”
BackgroundPREPARATION AND CHARACTERIZATION OF A PLASMA MEMBRANE FRACTION FROM ISOLATED FAT CELLS
McKeel, D. W., & Jarett, L. (1970) · The Journal of Cell Biology · doi:10.1083/jcb.44.2.417 · Cited by 400
Research works printed but not linked: 1
- Schwabe U (1985) Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol Suppl 329: R37
Cited by
Items 101–156 of 156
Featherstone, R. L., Chambers, D. J., & Kelly, F. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.3.9910038 · Cited by 13
Pentoxifylline as a therapeutic option for pre‐eclampsia: a study on its placental effects
Broekhuizen, M., VRIES, R. D., Smits, M., Dik, W. A., Schoenmakers, S., Koch, B. C. P., Merkus, D., Reiss, I. K. M., Danser, A. H. J., Simons, S. H. P., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15931 · Cited by 14
“Pentoxifylline has a higher selectivity for the A1 versus the A2 receptor (Schwabe et al., 1985) and would thus be expected to induce vasodilation by blocking the effects of”
BackgroundHarvey, A. L., Young, L., Kornisiuk, E. E., Snitcofsky, M., Colettis, N. C., Blanco, C., Jerusalinsky, D. A., Jamieson, A. G., Hartley, R. C., & Stone, T. W. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.06.023 · Cited by 11
King, B. F. (1994) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(94)90159-7 · Cited by 12
G-Protein-Coupled Receptor and Ion Channel Genes Used by Influenza Virus for Replication
Orr‐Burks, N., Murray, J., Todd, K. V., Bakre, A. A., & Tripp, R. A. (2021) · Journal of Virology · doi:10.1128/jvi.02410-20 · Cited by 14
Frauman, A. G., & Moses, A. C. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92446-7 · Cited by 12
Wu, Y., Gao, J., Yan, S., Wu, C., & Hu, B. (2019) · The Journal of Chemical Thermodynamics · doi:10.1016/j.jct.2019.06.007 · Cited by 11
Elmenhorst, D., Garibotto, V., Prescher, A., & Bauer, A. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.10.068 · Cited by 11
Dilatory effects of phosphodiesterase inhibitors on human hand veins in vivo
Großmann, M., Braune, J., Ebert, U., & Kirch, W. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050417 · Cited by 11
Zhu, X., Zhu, J., Wang, Y., Chu, Z., Wang, R. K., Xu, Y., Lu, L., & Zou, H. (2022) · BMC Ophthalmology · doi:10.1186/s12886-022-02638-x · Cited by 11
“Possible explanations are that caffeine acted as a competitive inhibitor of A1, A2a, and b-adenosine receptors, and increased nitric oxide production, to shift the balance between vasodilatory and contractile mechanisms [6, 20].”
BackgroundMing, M., Manzini, I., Le, W., KRIEGLSTEIN, K. G., & Spittau, B. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22843 · Cited by 10
“Caffeine is an adenosine receptor antagonist and an inhibitor of adenosine 30,50-cyclic monophosphate (cAMP) phosphodiesterase [Schwabe et al., 1985] which increases the levels of cAMP.”
BackgroundAlmeida, B. A., Morales, A. P., Ribeiro, J. R. C., Sampaio-Jorge, F., Ribeiro, Y. G., Barth, T., & Ribeiro, B. G. (2024) · Current Cardiology Reviews · doi:10.2174/011573403x289842240307114736 · Cited by 9
Adenosinergic mechanisms in anticonvulsant action of diazepam and sodium valproate
Katyal, J., Seth, S. D., Gupta, S. K., & Gupta, Y. K. (1996) · Environmental Toxicology and Pharmacology · doi:10.1016/1382-6689(96)00020-8 · Cited by 9
Ribeiro, J. A., & Monteiro, E. C. (1991) · Nucleosides and Nucleotides · doi:10.1080/07328319108047232 · Cited by 9
Khoury, W., Trus, R., Chen, X., Baghaie, L., Clark, M., Szewczuk, M. R., & El-Diasty, M. M. (2023) · Cells · doi:10.3390/cells12081199 · Cited by 8
Seng, K., Teo, W. G., Fun, D. C. Y., Law, L. Y. L., & Lim, C. L. (2010) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.714 · Cited by 8
“Theophylline also acts as an adenosine receptor antagonist [34].”
Theophylline improves functional recovery of isolated rat lungs after hypothermic preservation
Featherstone, R. L., Kelly, F. J., & Chambers, D. J. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00039-9 · Cited by 8
Kaplita, P. V., Abreu, M. E., Connor, J. R., Erickson, R. H., Ferkany, J. W., Hicks, R. P., Schenden, J. A., Noronha‐Blob, L., & Hanson, R. (1990) · Drug Development Research · doi:10.1002/ddr.430200403 · Cited by 8
Wördemann, M., Fandrey, J., & JELKMANN, W. E. B. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.1069 · Cited by 8
Intravenously infused adenosine increases the blood flow to brown adipose tissue in rats
Uchida, Y., & Nomoto, T. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90613-b · Cited by 7
Discovery and recognition of purine receptor subtypes on platelets
Hourani, S. M. O. (2001) · Drug Development Research · doi:10.1002/ddr.1108 · Cited by 7
Ain, R., & Seshagiri, P. B. (1998) · Reproduction Fertility and Development · doi:10.1071/r97052 · Cited by 7
Miziak, B., Błaszczyk, B., Chrościńska–Krawczyk, M., & Czuczwar, S. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417569 · Cited by 6
“Caffeine, structurally a 1,3,7-trimethylxanthine, is a nonselective antagonist of adenosine receptors [1].”
BackgroundShukla, R., Bandopadhyay, P., Sathe, M., & Chopra, D. (2020) · Journal of Chemical Sciences · doi:10.1007/s12039-019-1726-2 · Cited by 6
Effect of adenosine and adenosine agonists on amylase release from rat pancreatic lobules
Nodal, F. R., Román, J. I. S., López-Novoa, J. M., & Calvo, J. J. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02140-e · Cited by 6
Rivilla, F., Güemes, M., Sánchez‐Ferrer, C. F., Ibañez, C., Salaíces, M., & Marı́n, J. (1990) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1990.tb06600.x · Cited by 6
Korzycka, L., & Górska, D. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.5.0010 · Cited by 6
“All xanthine derivatives with 7-position substituents, such as dyphylline and proxyphylline, were found to be weaker antagonists of A1 and A2 receptors than xanthine (Schwabe et al 1985).”
Rose’Meyer, R. B., Headrick, J. P., Peart, J. N., Harrison, G., Garnham, B., & Willis, R. J. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03389.x · Cited by 6
METHYLXANTHINES IN SURGERY: A BRIGHT FUTURE?
Tuckey, J. A., Parry, B. R., & McCall, J. L. (1992) · Australian and New Zealand Journal of Surgery · doi:10.1111/j.1445-2197.1992.tb07550.x · Cited by 5
Sommerauer, M., Ateş, M., Gühring, H., Brune, K., Amann, R., & Peskar, B. A. (2001) · Pharmacology · doi:10.1159/000056139 · Cited by 5
Xanthine Interference with Dipyridamole—Thallium-201 Myocardial Imaging
Standi, E. J., Melko, G. P., & Charland, S. L. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900414 · Cited by 5
Purinergic and cyclic AMP modulation of noradrenaline release in cat femoral arteries
Güemes, M., Rivilla, F., Sánchez‐Ferrer, C. F., & Marı́n, J. (1990) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(90)90604-k · Cited by 5
Yan, C., Wei, G., Jin, Z., Li, X., Yang, L., Zou, L., & Yang, L. (2025) · Engineering · doi:10.1016/j.eng.2025.07.029 · Cited by 6
The effect of torbafylline on enzyme activities in fast and slow muscles with limited blood supply
Egginton, S., & HUDLICKÁ, O. (1991) · Comparative Biochemistry and Physiology Part C Comparative Pharmacology · doi:10.1016/0742-8413(91)90094-a · Cited by 6
Postlethwaite, M., Constanti, A., & Libri, V. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703236 · Cited by 4
Competitive Inhibition as a Tool to Modulate and Predict Dynamic Hydrogel Mechanics
Claiborne, A. D., Mekcham, S., Lee, O. A., & Hill, M. R. (2026) · ACS Central Science · doi:10.1021/acscentsci.5c02130 · Cited by 3
Featherstone, R. L. (2004) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1016/s1569-9293(03)00274-3 · Cited by 3
“Interestingly, theophylline also acts as an adenosine receptor antagonist [7], so the superiority of theophylline in protecting lungs may be due to combined PDE inhibitory activity and adenosine antagonism (mimicking preconditioning [4]).”
BackgroundAdenosine Receptors Mediating Inhibition of Peripheral and Central Neurons
Ribeiro, J. A., & Sebastião, A. M. (1990) · Springer eBooks · doi:10.1007/978-1-4612-3400-5_26 · Cited by 3
Adenosine affects the calcium dynamics of rat portal vein
Telang, R. S., Tripathi, H. C., Mishra, S. K., & Raviprakash, V. (2003) · Autonomic and Autacoid Pharmacology · doi:10.1046/j.1474-8673.2003.00294.x · Cited by 2
Effect of tienoxolol, a new diuretic β‐blocking agent, on urinary prostaglandin excretion in the rat
Caussade, F., & Cloarec, A. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13565.x · Cited by 2
Mechanisms of Xanthine Actions in Models of Asthma
Howell, R. E., Gaudette, R. F., Raynor, M. C., Warner, A., Muehsam, W. T., Schenden, J. A., Perumattam, J. J., Hiner, R. N., & Kinnier, W. J. (1990) · Springer eBooks · doi:10.1007/978-1-4612-3400-5_54 · Cited by 2
Hausleithner, V., Freissmuth, M., & Schütz, W. (1986) · Journal of Receptor Research · doi:10.3109/10799898609074817 · Cited by 2
Peracchia, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169017 · Cited by 1
“Lack of an involvement of adenosine receptor inhibition is also provided by the absence of an effect of IBMX on heptanol-induced Rj rise (Figure 7) [16]; indeed, IBMX, as caffeine and theophylline, is also an inhibitor of adenosine receptors [23,24].”
BackgroundMoser, P. C. (1993) · Drug Development Research · doi:10.1002/ddr.430300403 · Cited by 1
Properties of Adenotin Reconstituted into Phospholipid Vesicles
Hutchison, K. A., Prasad, M., Work, C. W., & Fox, I. H. (1991) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199101000-00001 · Cited by 1
Gauthier, C., & Soustre, H. (1991) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1991.tb01241.x · Cited by 1
Björkman, F., Engström, J., Helge, T., & Ekblom, Ö. (2026) · European Journal of Applied Physiology · doi:10.1007/s00421-026-06182-0
“Its physiological effects stem from stimulation of the nervous system, mainly through adenosine receptor blockade (Schwabe et al. 1985) and increased activity of the autonomic nervous system, resulting in the release of plasma catecholamines, with dose-dependent increases in blood pressure (BP)…”
P1 and P2 Receptors in Platelets
Hourani, S. M. O. (2001) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-56921-0_5
Wells, J. N., Nieves, L., & Katsushima, T. (1990) · Springer eBooks · doi:10.1007/978-1-4612-3400-5_53
RENE E CAFFEINA: UN BREVE "UPDATE"
Buemi, M., Bolignano, D., Coppolino, G., Crascì, E., Aloisi, C., Campo, S., & Sturiale, A. (2007)
36 and Characterization of Purinoceptors
Burnstock, G. (1990)
Sampaio-Jorge, F., Morales, A. P., Pereira, R., Barth, T., & Ribeiro, B. G. (2021) · Research Square · doi:10.21203/rs.3.rs-817148/v1
Gong, Z., Yu, S., Lyu, Z., Huang, W., & Zhang, T. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2670558
“Meanwhile, caffeine also functions as a competitive inhibitor, binding to A1, A 2a , and A 2b adenosine receptors [38].”
Metadata
- Authors
- Schwabe, U., Ukena, D., & Lohse, M. J.
- Affiliations
- Heidelberg University (DE)
- ORCID
- Lohse, M. J.
- Venue
- Naunyn-Schmiedeberg's Archives of Pharmacology
- Published
- 1985-09
- Volume
- 330
- Issue
- 3
- Pages
- 212-221
- ISSN
- 0028-1298 (ISSN-L)
- 1432-1912
- OpenAlex
- W2015172541
- Cited by
- 153
- References
- 34
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 4 · 2020: 1 · 2019: 3 · 2018: 3 · 2017: 1 · 2016: 1 · 2014: 2 · 2013: 1 · 2012: 2
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Naunyn-Schmiedeberg s Archives of Pharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- xanthine derivatives, adenosine A1 receptor, adenosine A2 receptor, adenosine receptor antagonists, 8-phenyltheophylline, theophylline, caffeine, 3-isobutyl-1-methylxanthine, diprophylline, pentoxifylline, receptor subtype selectivity, human platelets, cerebral cortex, adipocytes
- MeSH terms
- Adenosine, Adenosine Diphosphate, Adenylyl Cyclases, Adipose Tissue, Animals, Blood Platelets, Brain Chemistry, Cattle, Cell Membrane, Humans, Male, Rats, Inbred Strains, Receptors, Cell Surface, Receptors, Purinergic, Xanthines, Adenosine-5'-(N-ethylcarboxamide), Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.